BCIQ Profiles

Company Profile Report
0909 Mammoth series C+D EMBARGO Thurs 9AM PT
BioCentury & Getty Images


Mammoth hits the gas on therapeutic development with $195M in fresh funding

Doudna-founded biotech advancing in vivo CRISPR therapies with pair of new financings

Doudna-founded Mammoth is advancing its in vivo CRISPR therapies with a pair of new financings.

Sep 9, 2021 | 1:00 PM GMT

With a diagnostics platform

Read the full 576 word article

How to gain access

Continue reading with a
two-week free trial.